(Q34827671)

4 August 2017

title

Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies (English)

1 reference

Helicobacter pylori infectious disease

4 August 2017

0 references

1 reference

2

Jin Il Kim

1 reference

4 August 2017

Hyun Jeong Lee

1

1 reference

4 August 2017

Jin Soo Lee

3

1 reference

4 August 2017

Eun Jung Jun

4

1 reference

4 August 2017

Jung-Hwan Oh

5

1 reference

4 August 2017

Dae Young Cheung

6

1 reference

4 August 2017

Woo Chul Chung

7

1 reference

4 August 2017

Byung-Wook Kim

8

1 reference

4 August 2017

Sung Soo Kim

9

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

World Journal of Gastroenterology

4 August 2017

published in

1 reference

4 August 2017

volume

21

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

351-359

1 reference

Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Standard triple, bismuth pectin quadruple and sequential therapies forHelicobacter pylorieradication

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Helicobacter pylori treatment in the era of increasing antibiotic resistance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Clinical practice. Helicobacter pylori infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Sequential therapy for Helicobacter pylori eradication: a critical review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Smoking increases the treatment failure for Helicobacter pylori eradication

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

The importance of efflux pumps in bacterial antibiotic resistance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea

8 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I1.351

Ten-day sequential therapy of Helicobacter pylori infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I1.351

Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I1.351

Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I1.351

[Changes in the eradication rate of conventional triple therapy for Helicobacter pylori infection in Korea]

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

[Helicobacter pylori eradication therapy in Korea]

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Clarithromycin-resistant genotypes and eradication of Helicobacter pylori

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Patterns of alcohol consumption and Helicobacter pylori infection: results of a population-based study from Germany among 6545 adults

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284355

A new highly effective short-term therapy schedule for Helicobacter pylori eradication

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25574111

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25574111

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of two different treatment protocols in Helicobacter pylori eradication

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25574111

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V21.I1.351

1 reference

4 August 2017

1 reference

4 August 2017

1 reference